Tower Research Capital LLC (Trc) Anebulo Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,750 shares of ANEB stock, worth $4,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,750
Previous 3,252
46.19%
Holding current value
$4,130
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ANEB
# of Institutions
22Shares Held
22.2MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$36.5 Million25.71% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$7.17 Million0.29% of portfolio
-
Mangrove Partners New York, NY2.53MShares$5.96 Million0.77% of portfolio
-
Morgan Stanley New York, NY399KShares$942,5930.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA307KShares$723,4340.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $60.5M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...